GLMD
Galmed Pharmaceuticals LtdPINK
Updated 8 days ago
Coverage limited
$4.63+21.05%
Close Sep 9, 2026
- Market cap
- $3.81M
- 1 month
- -2.4%
- 3 months
- +10.9%
- 1 year
- -57.8%
- Dividend
- No dividends on record
- Short interest
- 19.6K sharessettled Aug 31, 2026 · -47.3% since Aug 14, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if GLMD is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
2 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Insider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
12 filers reported a long position in GLMD for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| CITADEL ADVISORS LLC | $48.3K | 86.9K | +663.1% |
| HRT FINANCIAL LP | $23K | 42.1K | New |
| XTX Topco Ltd | $8.4K | 15K | -33% |
| TWO SIGMA SECURITIES, LLC | $6.1K | 11K | -8% |
| SBI Securities Co., Ltd. | $37 | 66 | +312.5% |
| MORGAN STANLEY | $31 | 56 | -64.3% |
| WELLS FARGO & COMPANY/MN | $24 | 43 | Unchanged |
| Federation des caisses Desjardins du Quebec | $8 | 14 | Unchanged |
| Allworth Financial LP | $2 | 2 | Unchanged |
| UBS Group AG | $2 | 3 | -99.9% |
Get the Full Analysis for GLMD
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.